Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Federal rulemaking freeze would end Dec. 31 at latest under House committee mark-up.

This article was originally published in The Gray Sheet

Executive Summary

FEDERAL RULEMAKING FREEZE WOULD END DEC. 31 AT THE LATEST under an amendment to HR 450 adopted by the House Government Reform and Oversight Committee during mark-up on Feb. 13. The amendment to the "Regulatory Transition Act of 1995" states that the regulatory moratorium would end either on Dec. 31, 1995 or when regulatory reform legislation is enacted, whichever occurs first.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts